46% power in study planning? [Study As­sess­ment]

posted by sam – India, 2013-08-02 09:00 (4301 d 06:33 ago) – Posting: # 11160
Views: 25,662

Hi John

❝ If outlier test confirms then one option is to do a rechallenge study -> Run another small study with the questionable subjects along with a few controls.


Will the USFDA accept the data after exclusion of the subjects if the re-dosing confirms the outlier.

Regards

Sam

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
133 visitors (0 registered, 133 guests [including 5 identified bots]).
Forum time: 15:33 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5